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Postreceptor Signal Transduction by Cyclic Adenosine
Monophosphate and the Ca"-Calmodulin Complex
To survive in a dynamic environment, all living cells must be
able to identify and respond to variations in specific extracel-
lularsignals. Peptide hormones are one type of signal to which
mammalian cells respond. Cells recognize hormones through
specific receptors on the outer surface of the plasma mem-
brane. The binding of a hormone to its receptor initiates a
series of rapid events that eventually translate this external
signal into a specific cellular response mediated by a selective
alteration of intracellular metabolism. These metabolic re-
sponses include ion flux, enzyme activity, RNA and protein
synthesis, steroid synthesis and secretion, protein secretion,
cell division, cell motility, and cell-to-cell communication.
The mechanism by which the extracellular event is translated
into these intracellular events is not completely understood.
However, it is now well accepted that virtually all of the
intracellular events triggered by peptide hormones are related
to changes in the concentration of two "second messengers"
namely, cyclic adenosine monophosphate (cAMP)' and Ca".
The mechanisms of action of these intracellular messengers
are in some ways similar. Nonmuscle cells possess a single
receptor for each of these two messengers. Calmodulin con-
stitutes the primary receptor for Ca" (1, 2), whereas the
regulatory subunits of cAMP-dependent protein kinase are
the predominant CAMP-binding proteins in eukaryotic cells
(3, 4). The interaction of Ca21 with calmodulin causes a
conformational change in this protein so that it can interact
with a variety of enzymes to produce a stimulation (5-7).
Thus, calmodulin can be considered a receptor, and the
enzymes regulated by the Ca"-binding protein can be consid-
ered as "acceptor" proteins. Similarly, for the cyclic nucleotide
system, the binding of cyclic nucleotides to the regulatory
components of protein kinase produces a conformational
change that, in all cases, is accompanied by phosphorylation.
These events result in the release ofcatalytic activity. Catalytic
activity can also be regulated by the presence oflow molecular
weight protein kinase inhibitors. These protein inhibitorshave
been found in virtually all eukaryotic cells and are competitive
inhibitors for the substrates of the catalytic subunit of the
cAMP-dependent protein kinase (8-10). The purpose ofthis
'Abbreviations used in this paper: cAMP, cyclic adenosine mono-
phosphate; FSH, follicle-stimulating hormone.
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article is to review the contributions made by the workers in
our laboratory to our knowledge ofthe mechanisms by which
CAMP and the Ca"-calmodulin complex affect the regulation
of intracellular events related to motility.
Regulation of Motility
It has been proposed that both cAMP and Ca" are involved
in the regulation of the secretion of specific products from
cells. In many instances the effects of these two intracellular
messengers appear to be antagonistic, but additive or syner-
gistic effects of Ca" and cAMP have also been reported (see
references 1 and 4 for reviews). At least two components of
the cellular cytoskeleton have also been implicated in the
secretory process. Microtubules constitute a network that
defines and orients the flow of secretory granules from their
site of synthesis and packaging in the Golgi apparatus to the
site of discharge at the plasma membrane. Microfilament
bundles could provide the motive force for the fusion ofthe
granules to the plasma membrane and/or exocytosis of the
products. Calmodulin-binding proteins have been identified
on secretory granules (11) and as components of the actin-
binding proteins associated with the plasma membrane (12).
The interaction of Ca" and CAMP in the control of motility
and secretion can be appreciated by consideration of the
intracellular localization ofthe structuraland regulatory mol-
ecules involved. Calmodulin, myosin light chain kinase, and
myosin light chains (LC2o) are localized on actin-containing
microfilament bundles in interphase cells (1, 13, 14). Protein
kinase inhibitor (15), the regulatory (16) and catalytic (17)
componentsof cAMP-dependent protein kinase, and tubulin
(18) are all associated with microtubules.
Calcium binds to calmodulin, allowing interaction of this
complex with myosin light chain kinase. Phosphorylation of
myosin light chains by this activated enzyme promotes a
conformational change that allows stimulation of myosin
ATPase. Hydrolysis of ATP provides the energy necessary for
tension development and motility (19). Cyclic AMP binds to
the regulatory component of cAMP-dependent protein ki-
nase, releasing the active catalytic subunit (3). This enzyme
phosphorylates the a- and ,B subunits of tubulin, resulting in
the enhanced polymerization of microtubules in interphase
cells (20) or flagellar motility (in spermatozoa) (21). Both
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cAMP are positive reactions resulting from stimulation of
microfilaments or microtubules, respectively. On the other
hand, the Ca"-calmodulin complex can causea depolymeri-
zation of microtubules. This effect has been observed in vitro,
(22) in vivo afterthe microinjection of calmodulin into living
cells (23), and in situ in a lysed cell system (20). CaZ+-
calmodulin also attenuates the stimulatory effect ofCAMP on
sperm motility. Calmodulin can be found associated with
cytoplasmic microtubules (24) as well as microfilaments (5).
These associations are Ca" independent, whereas the regula-
tion of enzyme activities on these organelles requires Ca"
bound to calmodulin. Thus,calmodulin can serve a structural
role by binding to other proteins in the absence of CaZ+ and
yet still respond to alterations in CaZ+ concentration by
undergoing a conformational change and activating specific
enzymes. Finally, phosphorylation of the myosin light chain
kinase by CAMP-dependent protein kinase markedly de-
creases the affinity of this enzyme for CaZ+-calmodulin (25).
This reaction could be one mechanism by which cAMP
antagonizes at leastone positive effect ofCaZ+. Together, these
observations suggest that cell motility, as exemplified by ex-
ocytosis, is regulated by the ratioofcAMP to Ca2'-calmodulin
in the cytoplasm.
Regulation of Energy Production
It is generally accepted that protein phosphorylation is the
major common mechanism by which intracellular events in
eukaryotic cellsare controlled by external physiologic stimuli.
Whereas calcium and cAMP enjoy widespread acceptance as
the two primary mediators of ligands that bind to cell surface
receptors, it is only recently that the idea has been considered
that widely divergent cellular processes are regulated by com-
mon phosphorylation-dephosphorylation reactions (4). We
have offered one explanation of how the common mecha-
nisms apply to the regulation of motility and contractility.
One point still to be considered is how nonmuscle cellssupply
the energy required for motile responses mediated by calcium
and cAMP. Glycogen is the primary source of energy for
muscle contraction. Synthesis and degradation of this com-
plex carbohydrate are regulated by the hormones epinephrine
and insulin as well as by the contractile state of the tissue.
Regulation is through changes in the phosphorylation state of
glycogen phosphorylase and glycogen synthase. These changes
are subserved by a discrete number ofprotein kinases, protein
phosphatases, and regulatory components. In every case, the
regulatory componentsare modulated by CAMP and calcium.
Evidence is now emerging that the energy required for
motility in nonmuscle cells is generated in a manner analo-
gous to energy generation in muscle. The rat testis Sertoli cell
containsglycogen, glycogen synthetase, phosphorylase kinase,
and phosphorylase (26). The peptide hormone follicle-stimu-
lating hormone (FSH) markedly alters the phosphorylase
activity ratio, leading to glycogen breakdown and energy
production. The phosphorylase in the Sertoli cell is activated
by an increase in the intracellular concentration of either
CAMP or calcium. The mechanism includes conversion of
inactive phosphorylase b to active phosphorylase a by phos-
phorylation. The converting enzyme phosphorylase kinase
also is activated by phosphorylation. In the Sertoli cell (as in
muscle) this phosphorylation occurs via the catalytic subunit
of CAMP-dependent protein kinase released in response to
FSH-induced cAMP accumulation. In addition, increases in
intracellular calcium also stimulate phosphorylase kinase in a
manner mediated by interaction with a constitutive calmod-
ulin subunit (4).
Glycogen-multienzyme complexes found in muscle consist
not only of the polymer and the enzymes directly involved in
glycogen synthesis and degradation but also of the enzymes
necessary to degrade glucose to lactate (27). These complexes
have been found by electron microscopy to be localized in
muscle at the I band of the sarcomere and are thus in close
proximity to the contractile elements. FSH not only stimu-
latesglycogen breakdown in the Sertoli cell but also stimulates
conversion of glucose to lactate and pyruvate, which are the
preferred substrates for the surrounding germ cells (28, 29).
Therefore, the glycolytic enzymes are also present in the
Sertoli cell and are regulated by changes in cAMP and cal-
cium. The structure analogous to the muscle sarcomere in
nonmuscle cells is the microfilament bundle. These structures
contain actin, myosin, and all of the regulatory proteins
required to control contractility. Phosphorylase has recently
been shown by indirect immunofluorescence microscopy to
be associated with the stress fibers in Sertoli cells (26). In
addition, this localization was abolished by incubation ofthe
cells with «-amylase, which suggests the association of phos-
phorylase with glycogen particles.
The localization ofphosphorylase on Sertoli cell stress fibers
could be a mechanism by which the two mediators of post-
receptor signal transduction, cAMP and calcium, regulate the
production of ATP required for myosin ATPase. The local-
ization of a metabolic complex at the site ofenergy utilization
provides an efficient mechanism for coupling an energy-
requiring motile structure with an energy-producing system.
Even though glycogen may provide a small proportion ofthe
total energy requirements for nonmuscle cells such as the
Sertoli cell, its localization on stress fibers might permit these
cells to reserve this energy for specific functions associated
with cytoskeletal movement. In this way the Sertoli cell could
rapidly respond to changes in CAMP or Ca" by microfil-
ament-induced shape changes and protein secretion.
Involvement of Calmodulin in the Regulation of
Cell Proliferation
The information summarized in the preceding sections
suggests that changes in the intracellular levels of calmodulin
also are important in the regulation ofcell function by Ca".
The first series of observations in this regard was somewhat
disappointing, because the expression of calmodulin levels,
even in target cells for both peptide and steroid hormones,
appears to be constitutive (1, 2, 30). However, calmodulin
levels are 2-10 times higher in several transformed cells (1, 2,
30, 31). This increase is regulated at the level of synthesis and
not degradation and occurs regardless of the nature of the
transforming agent (31). Thus, elevated levels of calmodulin,
determined by radioimmunoassay, have been reported in cells
transformed by RNA and DNA oncogenic viruses, chemical
carcinogens, or hormones (31). Calmodulin has also been
shown to be synthesized in a cell cycle-dependent manner.
Chafouleas et al. (32) found that calmodulin is increased by
a factor of two at the G,/S boundary of Chinese hamster
ovary cells. Moreover, treatment ofthese cells in exponential
growth with the anticalmodulin drug W13 results in the
selective but reversible inhibition of the progression through




2276the S phase. Further experiments revealed that this inhibition
of DNA synthesis was due to a single W13-induced block at
the G,/S boundary. The drug had no effect on progression
through G,, GZ, or M.
The calmodulin concentration also seems to be important
for the reentry of quiescent (plateau or Go) cells into the cell
cycle. Chafouleas et al. (33) have presented data indicating
that calmodulin plays a role in at least two distinct phases
during reentry of cells from the plateau phase into the cell
cycle. First, radioimmunoassay has shown that release from
plateau is associated with a decrease in calmodulin content
within the first hour. This rapidly occurring decrease results
in a calmodulin content similar to that found in G, cells after
cytokinesisand appears to be linked to the calmodulinmRNA
concentration in that an identical decrease in the calmodulin
mRNA also occurs upon release. The early decrease in intra-
cellular calmodulin is intrinsic to reentry into the cell cycle,
because it is observed when the cells are released by two
different methods. Indeed, these changes appear to be highly
correlated with reentry into the cell cycle, because the mag-
nitude ofthe change in calmodulin appears to be proportional
to the degree of synchrony of the released cultures. On the
other hand, analysis of fl-actin mRNA has revealed no de-
crease in content upon release, regardless of the method
employed. Thus, the decrease in mRNA appears to be selec-
tive for calmodulin. The involvement of calmodulin early in
quiescent cell release into the cell cycle has also been substan-
tiated by the observation that cells released directly into
medium containing W13 are markedly inhibited in their
ability to progress into S phase. However, this block is revers-
ible and cells begin to enter S phase 8-10 h after removal of
the drug. This lag period is exactly the same length for the
nontreated (control) cultures upon plateau release, which is
again consistent with a W13-induced block at a very early
stage in plateau release.
The mechanism by which calmodulin levels are rapidly
reduced during plateau reentry is unknown, but it may be
secondary to the rate oftranscription ofthe single calmodulin
gene. It is known that mRNA degradation is coupled with
rate of transcription in the case of the histories (34). Unfor-
tunately, this is not readily apparent when mRNAdegradation
is coupled to protein degradation in such an acute fashion.
The second phase of plateau release in which calmodulin
appears to be involved occurs approximately 5-8 h after
release. During this period there is a rapid increase in calmod-
ulin levels associated with the entry into S phase. This pattern
is similar to that observed during normal cell-cycle progres-
sion in Chinese hamster ovary cells (32) and occurs at a rate
compatible with the synthetic rate constants determined for
the protein by Chafouleas et al. (31). This change in protein
level is preceded by an increase in calmodulin mRNA. The
relative importance of calmodulin in this phaseofreentry was
also revealed by the studies with W 13. Cultures appear to be
susceptible to W13 treatment for at least the first 5 h of
plateau release. However, in contrast to treatment at 0 time,
an increasing number of cells enter S phase when treatments
are initiated further from release. Although cells enter S phase,
no progression through this phase can occur in the presence
of the drug. Analysis by flow cytometry have revealed that
this inhibition ofS phase progression is due to a block at early
S phase and not to a change in the transit time through S
phase. This effect of W13 on progression into and through S
phase in the plateau-released cells is similar to that observed
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for cells cycling normally (32). It would appear that this event
is similar to the normal G,/S transition.
The involvement of calmodulin in two distinct areas in
plateau release is further supported by W 13 reversal studies.
When cultures are treated with W 13 5 h after release, some
of the cells enter but do not progress through S phase. Re-
moval of the drug appears to reinstate progression in two
distinct populations of cells. First, the cells that are blocked
early in S phase progress through the S phase. This is then
followed by the synchronous entry into S phase of a second
populationofcells initially blocked in Go/G, . This subsequent
progression into S phase occurs 8-10 h after removal of the
drug and is identical to that observed for the cultures treated
at 0 h. Removal of the drug 5 h later only shifts this labeling
index profile to the right by exactly 5 h. These data are
consistent with reports of the existence of either two (35) or
three (36) steps in the Go-G,-S transition. In addition, recent
studies (37-40) performed on serum-deprived 3T3 cells have
demonstrated that reentry into the cell cycle can be broken
down into at least two distinct steps. The first is induction of
competence. Cells that have been rendered competent by such
mitogenic agents as platelet-derived growth factor are primed
for the next step, progression into S phase. Progression is
mediated by other growth factors and can only occur in
competent cells. Calmodulin may be involved in both ofthese
steps.
Recent experimental results obtained in our laboratory
(40a) can be interpreted as suggesting that the increase in
calmodulin at G,/S is important for optimal DNA repair
before replicative DNA synthesis. Bleomycin is known to
cause DNA damage by defined pathways. Concentrations of
this drug that result in potentially lethal damage to tissue
culture cells can be readily determined. Under such condi-
tions, -90% of the cells are killed. The remaining 10%,
however, can recover from the drug by repairing DNA and
eventually repopulate the culture dish. If cells are selected for
potentially lethal damage and released from bleomycin into
media containing W 13 (but not W12), all the cells are killed
within 3 h. The most obvious explanation of these results is
that calmodulinis required for DNA repair. When calmodulin
is neutralized with W13, cellscannot repair the DNA damage
caused by bleomycin. This results in cell death during the
subsequent replicative phase. However, the possibility existed
that the effect of W13 was not mediated via calmodulin.
Therefore, we evaluated the effects ofthis drug on growth and
DNA repair in bacteria. No effect of W13 was noted on the
growth of Escherichia coli, even at concentrations of up to
200 kg/ml. Moreover, when bleomycin was used to induce
DNA damage, W13 had no potentiating effect. Because pro-
karyotes do not contain calmodulin, this suggests that the
effects of W 13 seen in Chinese hamster ovary cells were due
to inhibition ofcalmodulin activities.
A more direct approach to the postulate that calmodulin is
involved in DNA repair was to examine the effects of W 13
on recovery from bleomycin-induced damage by the nucleoid
sedimentation assay described by Durkacz et al. (41). Nu-
cleoids are defined as nuclei treated with high salt to remove
the histories. Dispersion of the chromatin results in a char-
acteristic sedimentation when it is centrifuged through a
15-30% sucrose gradient. Damage to DNA results in a more
dispersed chromatin and, consequently, the nucleoids sedi-
ment more slowly. The difference in the distance migrated
between nucleoids from control and experimentally damagedcells is a measure of the degree of DNA breakage. The rate
and extent of recovery from such damage is related to the
ability of the cells to repair the DNA. W13 completely pre-
vents recovery from bleomycin-induced DNA damage, which
is further evidence that calmodulin is involved in the repair
process.
Calmodulin-binding Proteins Assessed by
Gel Overlay
If calmodulin is involved in DNA repair, then some of the
enzymes involved in purine and/or pyrimidine metabolism
(or that of other proteins involved in DNA repair) must be
regulated by calmodulin. It is known that such enzymes are
induced at the G,/S boundary, as is the case for calmodulin.
The correlate of this hypothesis is that specific calmodulin-
binding proteins also are induced before the G,/S boundary
in both normally cycling cells and in Go cells stimulated to
reenter the cell cycle. We have evaluated such changes in
calmodulin-binding protein during plateau reentry. The cal-
modulin-binding proteins were detected by the binding of
"'I-calmodulin to cellular proteins distributed on polyacryl-
amide gels (42, 43). By the inclusion of Mr standards it was
revealed that calmodulin could bind directly to glycogen
phosphorylase assessed by the gel overlay technique. Because
of the results of earlier studies on the Ca" regulation of
phosphorylase (4) and the fact that it colocalizes with calmod-
ulin (as determined by immunofluorescence microscopy) (26)
this fortuitous observation was further investigated.
The amount of calmodulin that bound to purified phos-
phorylase was compared with that that interacted with puri-
fied myosin light chain kinase. Conditions were manipulated
in such a way that the amount of 12'1-calmodulin bound to
each enzyme was directly proportional to the amount of
protein applied to the gel. Quantitation of the data obtained
revealed that phosphorylase and myosin kinase bound equal
amounts of calmodulin on a molar basis. In both cases the
binding was Ca2' dependent. These similarities suggested the
possibility that calmodulin directly interacts with phospho-
rylase in a Ca2'-dependent manner in vitro, as is the case in
the regulation of the activity of myosin kinase (14, 25).
Indeed, calmodulin activates both phosphorylase a and b
at a limiting concentration ofeither ofthe substrates glycogen
or glucose- l-phosphate. However, the affinity for calmodulin
is 1,000 times lower than that of myosin light chain kinase,
and activation is not Ca2' dependent. The activation ofphos-
phorylase is also not protein specific and can be mimicked by
other molecules, as diverse as troponin C and bovine serum
albumin, which exhibit similar binding constants. These ex-
periments illustrate the limitation of a correlation of the
characteristics of '111-calmodulin binding to a protein as de-
termined by the gel overlay technique with those assessed by
an independent assay, such as in vitro enzyme activation. The
properties predicted from the observation of calmodulin in-
teraction with proteins distributed on polyacrylamide gels
may, therefore, be quite different from those found when
binding is assessed by other independent techniques. Caution
should be exercised in interpreting the results of gel overlay
determinations if physiological relevance is the goal.
On the other hand,the gel overlay technique is a convenient
method by which to analyze a subset ofprotein in a complex
protein composition such as that in a totalcell extract. Appli-
cation of this procedure to Chinese hamster ovary cells in
plateau phase revealed approximately 20 proteins. Some of
these proteins bound '2'1-calmodulin only in the presence of
CaZ+, some bound in aqualitatively similar manner, regardless
of the Ca21 concentration, and some were detected only in
the presence ofEGTA. No demonstrable quantitative changes
occurred within the first 6 h after plateau release. Subse-
quently, however, proteins of four types were observed. Two
of these exhibited Ca-dependent and two Ca"-independent
'ZSI-calmodulin binding. The changes can be illustrated by
the following examples: (a) a 58,000-Mr Ca"-dependent pro-
tein that exhibited changes similar to those of calmodulin
(33); (b) a 51,000-M, Ca2'-dependent species that remained
unchanged for 18 h after release; (c) a 47,000-Mr protein
whose binding was independent of CaZ' (thisprotein showed
a continuous increase during reentry, reaching a level 10
times that present in quiescent cells 18 h after release); and
(d) a 28,000-Mr CaZ+-independent protein that began to de-
crease in amount until by 12 h after the mitogenic signal it
was no longer detectable. The identity and functional role of
these proteins are unknown. However, it is obvious that
dynamic changes in the protein composition of cells occur
during plateau reentry. Because the changes in the amount of
the 58,000-Mr protein were identical to those observed for
calmodulin, this molecule likely is a calmodulin-dependent
protein whose synthesis also is regulated at the G,/S bound-
ary. Future studies will be designed to evaluate this interesting
possibility.
Isolation and Characterization of Nucleic Acids
Encoding Calmodulin
The experiments summarized in the preceding sections
yielded data suggesting that cellular calmodulin levels could
be altered either by transformation or during the cell cycle at
the G,/S boundary. Because the transformed cell types used
in our study had a shorter cell cycle time than their nontrans-
formed counterparts (31), it is possible that the primary
intracellular regulation of calmodulin is cell cycle dependent.
To continue our search for the mechanism controlling cell
calmodulin level, we turned our attention to the cloning of
calmodulin cDNAs and genes. Because ofthe high concentra-
tion of calmodulin in the electroplax of the electric eel, we
used this tissue as a source of calmodulin mRNA. The first
cloned cDNA encoded the C-terminal 35% of calmodulin
(amino acids 93-148) and 182 nucleotidesofthe 3' noncoding
region (44). This recombinant molecule (pCM 109) was then
used to select a clone shown by DNA sequencing to contain
26 nucleotides of the 5' nontranslated region, the entire
coding region, and 408 nucleotides ofthe 3' noncoding region
(45). The noncoding region contained two polyadenylation
signals 280 nucleotides apart that both gave rise to functional
mRNAs. We concluded that a single 5,500-nucleotide pri-
mary transcript was used to produce three functional mRNA
molecules 2,000, 1,100, and 820 nucleotides in length.
The full-length eel clone pCM 116 was used to select cal-
modulin sequences from a cDNA library prepared from
chicken brain mRNA and from a chicken genomic library
constructed in a phage. Two overlapping cDNA clones were
sequenced and found to contain the entire coding region of
chicken calmodulin, together with 94 nucleotides of the 5'
nontranslated and 857 nucleotides of the 3' nontranslated
regions (46). The chicken cDNA clones were used to isolate
calmodulin gene sequences from the phage library. We now




2295have sequenced the entire gene from the ATG through the
transcription termination site. The gene is single copy and
contains at least six intervening sequences. The first of these
introns separates the ATG from the fast nucleotide of the
codon, which is translated into the N-terminal amino acid of
calmodulin (ala). The remaining introns are positioned as
follows: II between as 10 and 11; III between as 56 and 57;
IV between as 82 and 83; V between as 100 and 101 ; and VI
between as 139 and 140. Intervening sequences III, V, and
VI interrupt Ca2'-binding sites I, II, and IV, respectively,
whereas intron IV occurs in the linker that serves to divide
the two homologous halves of the protein. We have used a
70-nucleotide end-labeled fragment of the chicken cDNA
containing exclusively the 5' noncoding sequence to screen a
genomic cosmid library. We have isolated an additional re-
combinant containing 44 Kb of DNA, with 7.2 Kb being 5'
to the 5' terminus of our original a clone (CL-1). This
additional a clone (CL-2) is currently being evaluated for the
presence of the remaining 5' nontranslated region of the
chicken calmodulin gene.
A second calmodulin-related DNA sequence was obtained
by screening the chicken genomic library with the partial eel
clone pCM109 under relaxed conditions (60°C; 6x SSC. This
molecule, CM-1, is a single-copy gene that encodes a 148-
amino acid protein that bears an 87% sequence homology
with chicken calmodulin (47). This gene does not contain
intervening sequences but does possess a TATA box, an ATG
initiation codon, is in open reading frame, and has a single
polyadenylation signal 486 nucleotides from the TGA termi-
nation codon. This gene is flanked both 5' and 3' by a nine-
base pair direct repeat. These properties are similar to those
attributed to so-called processed genes. If this is true,CM-1 is
a reverse transcribed copy of the CL-1 processed transcript.
This copy, lacking introns, would be inserted back into the
genome. Hybridization analysis of poly A' RNA reveals the
presence of an mRNA in several chicken tissues that is
complementary to CM-1 (47). Such data are compatible with
the tissue specific expression of a processed calmodulin gene
and predict the presence of a calmodulin-like protein that
differs in 19 of the 148 amino acids from calmodulin.
Construction of Prokaryotic Expression Vectors
If the calmodulin-like gene CM-1 is expressed in a tissue-
selective manner, the encoded protein would be the first
calmodulin-like molecule to be demonstrated in a vertebrate
species. As a prelude to finding out whether this is true, we
decided to develop recombinant DNA molecules capable of
synthesizing the protein encoded by CM-1 . Methods devel-
oped to purify the protein from bacterial extracts could then
be applied directly to chicken tissues. In addition, an antibody
could be produced that would selectively recognize CM-1
protein (but not authentic calmodulin) and could be used to
localize this molecule in muscle as well as in other tissues and
cells. Even if CM-1 protein is not expressed in vivo, the
bacterially produced protein would be useful in determining
which domains of calmodulin are involved in which of its
many proposed functions. The protein encoded by CM-1
would have amino acid substitutions in Ca" binding domains
I, II, and IV (47). By taking advantage of common restriction
endonuclease sites in the three naturally occurring nucleic
acids available to us (45-47), we can engineer three additional
calmodulin-likeproteins with specific changes introducedinto
(a) domain I; (b) domain II; and (c) domains II and IV.
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Finally, bacterial expression vectors will allow us to metabol-
ically label calmodulin or the calmodulin-like proteins with
any isotope or radioactive amino acid desired. In this manner,
direct binding studies of unmodified proteins can be carried
out in vivo, in vitro, or using the gel overlay procedure.
A strategy was devised to construct an expression vector for
calmodulinusing the chicken cDNA (46), a pUC8 vector (48),
and a Tac promoter (49) as the DNA components. The
recombinant molecule was engineered so that the ATG was
seven nucleotides from the ribosome binding site of the lac
operon component of Tac. After introduction into a bacterial
host a colony was selected that produces 3% of its totalprotein
as calmodulin. The bacterially produced calmodulin appears
to be identical to rat testiscalmodulin by the followingcriteria:
(a) amino acid composition; (b) heat stability; (c) migration
on one- and two-dimensional denaturing gels, both in the
absence and presence ofCa"; (d) cross-reactivity in a specific
calmodulin radioimmunoassay (50); and (e) immunoprecipi-
tation with a polyclonal affinity purified calmodulin IgG.
The CM-1 gene was inserted into the calmodulin expression
vector in such a way that the ATG and first 10 amino acids
were encoded by chicken calmodulin, whereas the remainder
ofthe protein was encoded by CM-1 sequences. A clone was
selected in which, again, the level ofexpression was 3% ofthe
total protein. The CM-1 protein was characterized with re-
spect to rat testis and bacterially synthesized calmodulin. The
CM-1 protein is similar to calmodulin in that it is heat stable,
can be purified on phenothiazine-Sepharose, cross-reacts in a
calmodulin radioimmunoassay, and, in the presence of
EGTA, migrates identically to calmodulin on one-dimen-
sional SDS gels. CM-1 protein can be distinguished from
calmodulin in that it undergoes an aberrant Ca'-dependent
mobility shift on SDS gels and is more basic than calmodulin
upon analysis by two-dimensional gel electrophoresis. Finally,
CM-1 protein can be separated from calmodulin by chroma-
tography on thiol-Sepharose because it contains two cys resi-
dues and calmodulin does not. We now are using these
properties to determine whether the CM-1 protein exists in
chicken tissues. If the answer is yes, we will have the first
evidence for (a) expression of an apparently processed gene;
(b) presence of more than one functional calmodulin or
calmodulin-like gene in any species; (c) existence of a novel
calmodulin-like protein in a vertebrate; and (d) tissue-selec-
tive (or specific) expression of a calmodulin-like protein.
Future Perspectives
Even if the CM-1 gene is not expressed at the protein level,
we have capitalized on the fortuitous observation of the
presence ofa second calmodulin-like gene by using this DNA
to produce "mutant" calmodulin proteins in bacteria. These
proteins can be used to examine how calmodulin exerts a
variety of effects on a large number of specific metabolic
processes. As discussed above, calmodulin may play multiple
rolesin maintaining the structure and function of the cellular
cytomatrix. Calmodulin antibodies have been used to localize
this protein on cytoplasmic (24) and mitotic spindle (18, 51,
52) microtubules, cytoplasmic microfilament bundles (13),
and cytoplasmicintermediate filaments (53). Calmodulin pro-
motes the Ca2'-dependent disassembly of microtubules in
vitro (22) and when rnicroinjected into living cells in culture
(23). However, the effects of calmodulin in vitro can be
mimicked by skeletal muscle troponin C (22) and are not
inhibited by phenothiazine or naphthalene sulfonamide drugseither in vitro or in vivo (1, 24) . These observations suggest
that the portions of the calmodulin molecule involved in
microtubule binding and depolymerization are different from
those involved in the activation of enzymes such as cyclic
nucleotide phosphodiesterase (54) or myosin light chain ki-
nase (55). The bacterially produced calmodulin "mutant"
proteins can be used to directly examine whether this is so .
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